Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.59
- Piotroski Score 6.00
- Grade Outperform
- Symbol (BV)
- Company BrightView Holdings, Inc.
- Price $15.81
- Changes Percentage (-13.4%)
- Change -$2.45
- Day Low $15.02
- Day High $17.29
- Year High $18.89
BrightView Holdings, Inc., through its subsidiaries, provides commercial landscaping services in the United States. It operates through two segments, Maintenance Services and Development Services. The Maintenance Services segment delivers a suite of recurring commercial landscaping services, including mowing, gardening, mulching and snow removal, water management, irrigation maintenance, tree care, golf course maintenance, and specialty turf maintenance. Its customers' properties include corporate and commercial properties, homeowners associations, public parks, hotels and resorts, hospitals and other healthcare facilities, educational institutions, restaurants and retail, and golf courses. This segment's customer base includes approximately 13,000 office parks and corporate campuses, 8,000 residential communities, and 450 educational institutions. The Development Services segment offers landscape architecture and development services for new facilities and redesign projects. Its services include project design and management services, landscape architecture and installation, irrigation installation, tree moving and installation, pool and water features, sports field, and other services. BrightView Holdings, Inc. also operates as official field consultant to various league baseball. The company was founded in 1939 and is headquartered in Blue Bell, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/13/2024
- Fiscal Year End N/A
- Average Stock Price Target $13.50
- High Stock Price Target $18.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.31
- Trailing P/E Ratio 44.35
- Forward P/E Ratio 44.35
- P/E Growth 44.35
- Net Income $66.40 M
Income Statement
Quarterly
Annual
Latest News of BV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Analysis-BBVA's Sabadell bid mired in concerns over competition and Mexico
BBVA's bid for Sabadell faces delays due to Spanish regulators' phase 2 review, as Trump's election victory raises concerns over BBVA's Mexican business. Uncertainty looms as CNMC's examination may de...
By Yahoo! Finance | 2 days ago -
AbbVie's stock plummets over 12% after schizophrenia drug flops in Phase II trials
AbbVie's stock plummeted by 12% after its anti-psychotic drug, emraclidine, failed to meet primary endpoints in Phase II trials for schizophrenia treatment....
By Yahoo! Finance | 2 days ago -
Health Care Down as AbbVie, Humana Weigh -- Health Care Roundup
Health-care stocks fell due to concerns over AbbVie and Humana. AbbVie's shares dropped by over 12% following disappointing results from its schizophrenia drug trials. Conversely, Bristol Myers' stock...
By MarketWatch | 2 days ago
